Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30?Expressing Non-Hodgkin Lymphomas:Results of a Multicenter, Open-Labeled Phase II Trial
- Issued Date
- 2020
- Type
- Article
- Publisher
- CANCER RESEARCH AND TREATMENT
- Language
- 영어
- ISSN
- 1598-2998
- Citation Volume
- 52
- Citation Number
- 2
- Citation Start Page
- 374
- Citation End Page
- 387
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.